Introduction
============

The human macula is known to contain three yellow carotenoids, 3R,3'R-zeaxanthin, 3R,3'S (meso)-zeaxanthin, and 3R,3'R,6'R)-lutein ([@b9-opth-1-25]). These carotenoids are absorbed in the gut and ultimately deposited throughout the tissues of the eye. In the macula, for instance, the average concentration of lutein and zeaxanthin (LZ) is about 1 mM which is about three times higher than the average concentration of carotenoids in other tissues of the body ([@b47-opth-1-25]). This accumulation is conspicuous in terms of amount and selectivity. Of the 30--40 carotenoids typically found in the blood with very similar molecular configurations, only LZ are normally absorbed within ocular tissues. Within the eye, LZ are found in iridial tissue, the retinal pigment epithelium, the epithelium of the crystalline lens, and subretinal fluid ([@b15-opth-1-25]; [@b7-opth-1-25]). This predominance of LZ extends throughout most layers of the visual system. [@b18-opth-1-25] found that LZ are the dominant carotenoids within the brain comprising some 66%--77% of the total carotenoid concentration. The ubiquitous and selective presence of LZ within the visual system has led many researchers to believe that LZ play a special role in visual function and protection against visual disease. Although a number of comprehensive reviews have been written regarding the role of LZ in preventing age-related eye disease (cataracts and macular degeneration), a possible role of LZ in the early development of the visual system has received minimal attention. In this paper, we highlight the available evidence regarding possible functions of LZ early, as opposed to later, in life.

Lutein and zeaxanthin within food
=================================

Carotenoids are found in most fruits and vegetables with the exception of some root vegetables ([@b71-opth-1-25]). There exists over 500 different types of carotenoids in nature, but only about 30--40 are found within human sera with lutein, lycopene, and betacarotene tending to be the most abundant depending on diet composition. Because humans do not synthesize carotenoids, all carotenoids found within tissue must originate from the diet (or related sources like human milk or supplements). The richest sources of LZ within the diet are dark green leafy vegetables like spinach and kale that can contain 75--150 μg per gram of prepared food. Intermediate sources like broccoli, peas, maize, and lettuce can contain 10--30 μg per gram, and other sources like snap beans, carrots, and oranges tend to have less than 10 μg per gram ([@b40-opth-1-25]). Animal products like eggs and chicken skin can contain variable but significant amounts of LZ especially when marigolds are added to chicken feed to improve yolk or skin coloration ([@b60-opth-1-25]).

Lutein and zeaxanthin concentrations in breast milk and infant formula
======================================================================

The LZ content of breastmilk varies widely based on stage of lactation and individual diets ([Table 1](#t1-opth-1-25){ref-type="table"}). The largest survey of breast milk carotenoids included 471 mothers from nine sites around the world ([@b13-opth-1-25]). In this survey, individual LZ milk concentrations ranged from 3--232 μg/L. Mean concentrations at individual sites ([Table 1](#t1-opth-1-25){ref-type="table"}) ranged from approximately 15 μg/L in Australia, Canada, UK, and USA to approximately 43 μg/L in China and Japan. The average LZ concentration across all of these sites was 25 ± 19 μg/L.

In contrast to breast milk, commercial infant formulas generally contain only the LZ innate to the formula components. Using an HPLC method similar to [@b13-opth-1-25], [@b41-opth-1-25] measured three samples each of six brands of infant formula (three term and three preterm) and found an average lutein concentration of 0.07 μg/L with a range from 0--0.13 μg/L of lutein. For zeaxanthin, the formulas contained an average concentration of 0.005 μg/L with a range from 0--0.022 μg/L of zeaxanthin. The HPLC method used by [@b41-opth-1-25] includes a saponification step that is known to reduce the recovery of LZ by approximately 40% ([@b51-opth-1-25]) and therefore it is likely that the true LZ content of both breast milk and formula is likely higher.

Differences in serum lutein and zeaxanthin between breastfed and formula-fed infants
====================================================================================

A study of infant plasma carotenoid concentrations ([@b42-opth-1-25]) showed that breastfed and formula-fed infants had similar plasma LZ concentrations at birth (48 ± 15 μg/L and 49 ± 10 μg/L for breast and formula-fed, respectively). After one month, breastfed infant plasma LZ increased to 96 ± 64 μg/L while formula-fed infant plasma LZ decreased below baseline to 33 ± 19 μg/L ([Figure 1](#f1-opth-1-25){ref-type="fig"}).

Similar trends have been observed for other infant plasma carotenoids, with plasma concentrations of betacarotene ([@b64-opth-1-25]; [@b76-opth-1-25]), lycopene and cryptoxanthin ([@b76-opth-1-25]) all increasing above newborn levels over time in breastfed infants and dropping below newborn levels in formula-fed infants. Although the amounts of data are limited, it seems clear that if breast milk contains higher average levels of LZ which results in higher serum levels of LZ, then higher retinal levels are sure to result.

Lutein and zeaxanthin intake and serum concentrations in toddlers
=================================================================

The 2005 Dietary Guidelines for Americans recommend that children ages 2--3 consume one cup of vegetables per day at a caloric intake of 1000 kcal/day ([@b83-opth-1-25]). Specifically, this recommended vegetable intake should include one cup per week of dark green vegetables---the richest sources of LZ in the diet. According to the 2002 Feeding Infants and Toddlers Study (FITS), a national sample of US children 12--24 months old, mean vegetable intake in this age group was 0.4 cups per day ([@b25-opth-1-25]) with only 3.1% of non-Hispanic children consuming any dark green vegetables between the ages of 6--11 months increasing to 7.5% between the ages of 12--24 months ([@b57-opth-1-25]). This low vegetable dietary intake pattern would seem to present the risk of inadequate LZ consumption among toddlers as well.

Possible roles of lutein and zeaxanthin within the developing visual system
===========================================================================

Although LZ are found throughout the tissues of the eye, they are most highly concentrated within the inner layers of the fovea. The area around and including the fovea is called the macula and is of special clinical and scientific interest because it is here that we experience our best acuity and damage to this area leads to legal blindness. The cortical areas corresponding to the fovea are greatly magnified (eg, about half of V1 is devoted to processing information from the macula) reflecting the importance of this area for later information processing by the more anterior portions of the brain. The peripheral retina is essentially mature at birth but the fovea (ie, central 5 degrees) is so poorly developed as to be essentially nonfunctional ([@b1-opth-1-25]). Newborns can generally only discern vague shapes that are at a high contrast relative to their surroundings ([@b81-opth-1-25]).

In adults, the macula has the highest concentration of lutein found in the eye with a predominance of zeaxanthin isomers over lutein at a ratio of 2.4:1 ([@b8-opth-1-25]). In contrast, infants (0--2 years) have an incompletely formed and diffuse macula with lutein predominant over zeaxanthin at a ratio of 1.49:1 ([@b8-opth-1-25]). At birth, the area that will become the macula contains both rod and cone photoreceptors, and the photoreceptors themselves are short and immature ([@b39-opth-1-25]; [@b66-opth-1-25]). The change in lutein: zeaxanthin ratio appears to be closely related to steps in anatomical development.

Over the first 16 weeks of life, cone cells gradually become predominant in the fovea with a cone cell density similar to that found in adults resulting in improved infant visual acuity ([@b81-opth-1-25]). During this time frame, the outer plexiform layer also becomes discernable within the layers of the retina ([@b66-opth-1-25]). The outer plexiform layer (also called the fibers of Henle or receptor axon layer) is structurally relevant in that it contains the highest concentration of LZ in the retina ([@b75-opth-1-25]). These changes in the anatomical structure of the fovea are consistent with the shift in lutein: zeaxanthin ratio over this time period from a still lutein dominant profile (1.2--1.7:1) to a more adult profile of approximately 0.7:1 ([@b8-opth-1-25]). By four years of age, the photoreceptors have lengthened to near-adult lengths and the outer plexiform layer is fully formed ([@b66-opth-1-25]). During this same time period, the child's visual acuity also improves to near adult levels ([@b81-opth-1-25]).

Antioxidant functions of lutein and zeaxanthin
==============================================

The retina is uniquely susceptible to oxidative damage compared with other tissues. It is exposed to an intense energy source (ie, focused light from the lens) that can generate free radicals, high oxygen tension from the extensive vasculature of the retina, photosensitizing compounds, and a high concentration of an easily oxidized substrate (eg, DHA-rich outer segments). Under these conditions, the singlet oxygen free radical can be readily generated ([@b38-opth-1-25]). Singlet oxygen is electrophilic and preferentially reacts with molecules with a double bond (eg, DHA has six double bonds) in order to extract the hydrogen needed to return to ground state. When DHA loses a hydrogen atom from a double bond, it becomes a hydroperoxide free radical that can create more free radicals and begin a self-perpetuating chain reaction known as lipid peroxidation ([@b32-opth-1-25]).

LZ are particularly well suited for protecting the retina from oxidative damage compared with other chain-breaking antioxidants in the eye like alpha-tocopherol (vitamin E). Lutein, for instance, can return singlet oxygen to ground state by temporarily becoming triplet state L and then dissipating the energy as heat---a process that can be repeated over and over again since the lutein molecule remains intact after the energy transfer ([@b79-opth-1-25]). Alpha-tocopherol requires a donor antioxidant molecule to return to ground state after neutralizing singlet oxygen ([@b74-opth-1-25]). Lutein is also a more effective antioxidant than alpha-tocopherol both in preventing lipid peroxidation ([@b26-opth-1-25]) and oxidation initiated by the retinal photosensitizer A2-PE (composed of two all-trans retinal molecules and a phosphatidyletanolamine molecule) ([@b45-opth-1-25]). This latter effect is significant since A2E, the long-wavelength emitting flourophore of lipofuscin, is so cytotoxic to retinal pigment epithelium (RPE) cells and is thought to play an important role in the development of age-related macular degeneration ([@b73-opth-1-25]). Appropriately, LZ are found in significant amounts within the DHA-rich photoreceptor outer segments where they can most effectively provide antioxidant protection ([@b67-opth-1-25]). Additional evidence for antioxidant efficacy comes from the fact that when LZ is exposed to more free radical energy than can be dissipated as heat, specific LZ oxidation products are formed. These specific oxidation products have been identified in adult human eyes ([@b44-opth-1-25]) providing indirect evidence that LZ are acting as an antioxidant in vivo.

Antioxidant protection of the eye may be particularly important in infants. Infants cannot down-regulate blood flow in the retinal and choroidal vasculature as well as adults; therefore, these vessels deliver excess oxygen to the retina and favor the generation and proliferation of free radical peroxides ([@b38-opth-1-25]).

The role of lutein and zeaxanthin as an optical filter
======================================================

Since light must pass through LZ (ie, macular pigment) before reaching the receptors, it screens the vulnerable, lipid-rich outer retinal layers (eg, the receptoral outer segments and RPE) according to its spectral absorption profile. As shown in [Figure 2](#f2-opth-1-25){ref-type="fig"}, the macular pigments selectively absorb the portion of the visible spectrum from about 400--520 nm. Empirical data has shown that light can damage the retina depending on the wavelength of light, intensity and the length of exposure ([@b33-opth-1-25]). Light between the wavelengths of 700 nm (red) and 400 nm (blue) can pass through the cornea and lens and reach the retina efficiently to cause damage while ultraviolet and infrared light do not generally reach the retina ([@b69-opth-1-25]). Exposure to high intensity red light for a long period of time can produce thermal lesions on the retina (characterized by raising the temperature of the tissue at least 10 °C). In contrast, exposure to two-fold lower intensity blue light can produce photochemical lesions on the retina in the same amount of time and without raising the temperature of the tissue ([@b34-opth-1-25]). Such data have been used to calculate the "blue light hazard function" which is commonly used to define safe exposure limits to short-wave (ie, blue) light ([@b3-opth-1-25]). These standards are particularly important for occupations that require increased exposure to light between 400--500 nm (such as dentists using blue lasers to quickly cure dental compound). By absorbing actinic short-wave light before it damages the outer retina, macular pigment (MP) would reduce this damage (as shown by the similarity in the photoxic action spectral of the blue light hazard related to the MP absorbance spectra shown in [Figure 2](#f2-opth-1-25){ref-type="fig"}). Given equivalent light histories, an individual with high MP, would be expected to suffer less light-initiated damage over many years when compared with an individual with low MP.

Quantifying the effects of long-term exposure to visible short-wave light is challenging. The epidemiology, which tends to be cross-sectional, is mixed ([@b56-opth-1-25]). Of course, quantifying light damage over many years is very difficult, especially since, as noted later, so much of the damage could occur very early in life. Moreover, potentially moderating factors are often not considered. For example, there is no data that has considered the long-term effects of individual differences in MP levels. For this reason, laboratory studies using animal models are often used with the assumption that the effects are direct enough that they can be extrapolated to the chronic human situation. Nonhuman primates are the most appropriate models for eye research since they are the only animals that have maculas and accumulate MPs like humans. In a study where a blue light laser (476 nm) was used to induce photochemical lesions in monkey eyes, adult rhesus monkeys fed a LZ-deficient diet throughout life had more damage to their retinas than age-matched controls fed a normal chow diet. When deficient monkeys were then supplemented for 22--28 weeks with lutein or zeaxanthin (3.9 μmol/kg/d or about 10--15 mg per animal per day), the retina damage was significantly reduced compared with unsupplemented, carotenoid-deficient monkeys ([@b4-opth-1-25]). Supplemented monkeys also showed some changes in age-related eye damage (drusen particles) compared with unsupplemented, carotenoid-deficient monkeys indicating that LZ may reduce age-related damage to the eyes ([@b49-opth-1-25]). In the quail model, zeaxanthin supplementation (36 μg/kg diet) of carotenoid-deficient quail prevented photoreceptor apoptosis induced by intermittent bright white light exposure ([@b82-opth-1-25]). In rats, feeding 1 gram per day of *Lycium barbarum L*. fruit (wolfberry) to normal Sprague Dawley rats reduced the amount of retina damage induced by bright light exposure when compared with rats fed a normal diet ([@b59-opth-1-25]). *L. barbarum* is an extremely rich source of zeaxanthin containing 82 mg zeaxanthin per 100 g weight ([@b86-opth-1-25]). These experimental models show that dietary LZ can protect the retina from light damage, especially damage due to short-wave light.

If MP does protect the receptors and RPE from actinic damage, it is probably meaningful that individuals vary so widely in the amount of MP they possess. As measured in vivo in adult subjects, individual differences in MP density tend to be large, ranging from a maximum in some individuals of 1.5 optical density units at 460 nm (3% transmission) to a minimum of near zero density (100% transmission) ([@b35-opth-1-25]) (with an average density of about 0.36, SD = 0.22; [@b55-opth-1-25]). MP density in infants and children also varies between individuals ([@b8-opth-1-25]; [@b10-opth-1-25]). As noted, formula-fed infants with lower intake of LZ would be expected to have lower retinal levels compared with infants fed with LZ-rich breast milk.

Lower MP levels in children may be particularly meaningful since short wavelength (SW) light may pose a particular hazard to infants and young children. Infants are born with clear lenses that gradually yellow throughout life (due to color changes in proteins and other lens constituents). This yellowing progressively blocks the SW light passing through the lens as a linear function of age ([@b21-opth-1-25]). For example, [@b87-opth-1-25] obtained lens density data in subjects from birth until 70 years of age using visually evoked cortical potentials as the criterion response. He found that lens density at 400 nm increased (\~0.02 O.D. per year) by a factor of 22 when comparing the average one-month old with an average 70-year old. Expressed in relative terms, about 70%--80% of the SW light passes through the lens in 0--2 year olds, 60%--70% in 2--10 year olds but only 20% of SW light is transmitted in 60--90 year olds. Data from various sources is summarized in [@b69-opth-1-25].

Finally, filtering SW light may also have a number of meaningful optical effects as summarized by [@b63-opth-1-25]. These include: (1) reducing the effects of chromatic aberration; (2) decreasing glare discomfort and disability; (3) increasing visibility outdoors by absorbing "blue haze"; and (4) enhancing contrast (ie, by differential absorption of a background with shorter wavelengths than a target). Yellow filters like MP have also been shown to improve magnocellular function which could enhance reading performance, motion sensitivity, accommodation, and convergence particularly in reading-impaired children ([@b68-opth-1-25]).

Other possible influences of lutein and zeaxathin on neural function within the visual system
=============================================================================================

All of the major hypotheses of MP function are based on just two fundamental characteristics of the pigments: their filtering and antioxidant properties. In addition to their filtering and antioxidant properties, however, LZ have a number of other known characteristics that might have meaningful influences on the visual system. For example, although most highly accumulated in and around the foveal depression, LZ, unlike the many other carotenoids circulating in the blood, are found throughout the tissues of the eye ([@b90-opth-1-25]; [@b7-opth-1-25]) and at most layers of the visual system. [@b18-opth-1-25], for instance, found that LZ are the dominant carotenoids within the brain and comprise some 66%--77% of the total carotenoid concentration. There, these pigments would be optimally placed to influence central visual processing (eg, they are concentrated in the gray matter of the occipital region). LZ are also known to associate with the microtubules of axons. During embyogenesis, axons grow over extended distances to reach their targets. Once these targets have been achieved, the microtubules, cylindrical protein lattices, form the cytoskeleton of visual neurons. The walls of microtubules are formed by subunit proteins including tubulin. Whereas traditionally microtubules have been regarded as purely structural in nature, more recent evidence ([@b27-opth-1-25]; [@b53-opth-1-25], [@b54-opth-1-25]) has shown that they may serve mechanical signaling and communicative functions (eg, by influencing second-messenger systems). [@b6-opth-1-25] originally identified tubulin as a possible binding protein for the macular carotenoids. Using molecular modeling, [@b17-opth-1-25] confirmed tubulin as the most likely binding protein for retinal LZ and suggested that a major function of the macular carotenoids, previously unconsidered, is to modulate the dynamic instability of microtubules. In any event, LZ are found in many locations outside of the inner layers of the fovea, albeit at relatively low concentrations. They are also found in many locations within the cell including the cell membrane and cytoskeleton. It is possible that the presence of the pigments is simply incidental and has no actual function. It is also possible, however, that the pigments influence the function of the neurons that they so closely and structurally associate with.

The idea that the MP carotenoids might have an actual metabolic role is not new. [@b20-opth-1-25] originally suggested that LZ facilitate oxygen respiration within the fovea. The xanthophylls do often serve this function in hypoxic situations in other animals and plants ([@b43-opth-1-25]). The inner layers of the foveal depression, where MP is most densely concentrated, are typically avascular and hypoxic. LZ would, according to this idea, be positively related to oxygen metabolism, particularly in the fovea. For example, MP might be expected to be related to aspects of foveal architecture that might be expected to influence oxygen utilization (eg, the size of the avascular zone). Consistent with such a possibility, [@b2-opth-1-25] and [@b50-opth-1-25] found that retinal thickness (which would, presumably, cause greater hypoxia in the inner foveal layers due to less oxygen diffusion from the more distant posterior choroid) was positively related to MP density. [@b22-opth-1-25] originally suggested that lutein could influence blood flow (most probably including retinal blood flow) by preventing atherosclerotic changes through inhibition of low density lipoprotein-induced migration of plaque-forming monocytes to artery walls. As noted, [@b38-opth-1-25] argued that it was the absence of autoregulation of choroidal blood flow in the infant that leads to increased oxidative stress in the newborn retina.

Another possibly relevant feature of carotenoids is their ability to enhance gap junctional communication ([@b78-opth-1-25]). Gap junctions increase intracellular communication between glial and neuronal cells. Acting as portals, they influence propagation of action potentials, second-messenger systems and the movement of metabolites and electrolytes. Within the retina, gap junctions are crucial to light processing via lateral connections ([@b16-opth-1-25]; [@b84-opth-1-25]). Gap junctions may therefore be vital to the developing neural circuitry within the visual system ([@b70-opth-1-25]).

Evidence from such diverse sources suggests that, in addition to the classic hypotheses of MP function, LZ might play a facilitative role in neural processing. [@b31-opth-1-25] originally evaluated this possibility by measuring scotopic noise. It is generally thought that visual thresholds that depend primarily on receptoral processes are determined early in life. For example, most absolute thresholds are thought to reach adult levels between about 2--4 months ([@b11-opth-1-25]). Although intrinsic noise can arise at numerous levels of the visual system, noise associated with scotopic thresholds is thought to originate at the input stage (ie, at the level of the retina) ([@b85-opth-1-25]). When in a fully dark-adapted state (ie, scotopic), the visual system is maximally sensitive, making the effects of noise easily measurable. LZ are found within rod outer-segments and therefore a relation to rod function is feasible. As shown in [Figure 3](#f3-opth-1-25){ref-type="fig"}, intrinsic noise was significantly related to MP optical density (MPOD). Such a relation is biologically plausible. As noted, LZ are found throughout the retina including within rod outer segments ([@b67-opth-1-25]). It is likely that higher levels of LZ in the macula (ie, the MP values that were measured) correlate with LZ in the outer segments. Such a relation suggests that higher LZ levels in rod outer segments might help improve the efficiency of rod functioning leading to less variability in threshold response (their measure of noise).

[@b31-opth-1-25] suggest that MP might be related to dynamic receptoral function. There is evidence also that MP might be related to post-receptoral processing. [@b36-opth-1-25] found a moderately strong relation between MP and critical flicker fusion thresholds (CFF) that was independent of age. CFF is largely regarded as a measure of temporal processing speed. Evidence suggests that the CFF (the average of descending flicker and ascending fusion thresholds) is probably determined post-receptorally ([@b65-opth-1-25]; [@b19-opth-1-25]). This possibility is based on the observation that the retina (as measured by electroretinography) responds to flicker even after a subject has reported fusion ([@b12-opth-1-25]) and correlates with measures of cortical arousal like electroencephalogram ([@b29-opth-1-25]; [@b30-opth-1-25]). Thus, diseases and drugs that influence central nervous system function often influence CFF thresholds in the same direction ([@b30-opth-1-25]; [@b52-opth-1-25]; [@b19-opth-1-25]). For example, barbituates decrease CFF thresholds and amphetamines increase CFF thresholds. In most situations, a lower threshold implies increased sensitivity (eg, a lower energy threshold for detection means a higher sensitivity). In the case of flicker, however, a higher threshold for fusion implies a higher flicker sensitivity. Like the MP--noise relation, the MP--CFF relation reported by [@b36-opth-1-25] was not age-dependent (ie, it is also evident for the younger subjects). CFF thresholds (reviewed by [@b81-opth-1-25]) reach adult levels in early infancy as opposed to some other spatial vision functions, like vernier acuity, that develop much later (\~5--6 years of age) and appear not to be associated with MP (Engles et al in press).

Conclusion
==========

The question of how LZ influence the developing visual system is open. There is, however, convincing evidence that a lack of LZ from birth can produce distinct anatomical changes within the retina and RPE. For example, [@b48-opth-1-25] studied the effects of raising Rhesus monkeys on diets containing no LZ. Compared with monkeys raised on normal diets, these xanthophyll-free monkeys displayed changes in the anatomy of their RPE (eg, in the density and distribution of RPE cells) that could be largely reversed by supplementing LZ (especially in conjunction with n-3 fatty acids, a precursor of DHA) later in life. Their results suggested that LZ might be important to the maturation of the fovea based on metabolic effects not associated with protection. With respect to the latter, it is becoming increasingly clear that protection very early in life is critical to preventing degenerative disease later in life. Carotenoid-deficient monkeys also develop signs of premature aging and damage (drusen and transmission defects) in their maculas years earlier than these signs develop in normal chow-fed monkey ([@b61-opth-1-25]).

One might argue that humans evolved in an environment where dietary intake of carotenoid-rich fruits and vegetables was high (ie, most food is gathered in hunter and gathering societies). Humans also were exclusively breast-fed until relatively recently in our evolutionary history. Although the effects of deviation from this "natural state" are not known, they could be meaningful. Of course, empirical study of this question in humans is difficult. Randomized, placebo-controlled trials of infant formula with and without lutein could require many years of follow-up before changes in the retina and RPE are detectable. Until such data are available, there is reason to believe lutein may have long term benefits based both on animal data and by examining the mechanisms by which damage accumulates in the retina throughout life. For example, one mechanism through which early intake of LZ could have long-term health benefits is through reduction of cumulative eye damage. Over the course of life, a cellular waste product called lipofuscin accumulates in the RPE of the eye. Lipofuscin is a mass of oxidized proteins, lipids, and other compounds created through the incomplete digestion of photoreceptor outer segments in the lysosomes of RPE ([@b77-opth-1-25]). Lipofuscin cannot be transported out of the cell, and the accumulation of lipofuscin in RPE is accelerated by increased oxygen ([@b88-opth-1-25]), light exposure ([@b5-opth-1-25]) or the absence of macular pigment ([@b49-opth-1-25]). In vitro, LZ inhibit the formation of lipofuscin in cultured RPE ([@b80-opth-1-25]). The results of failing to forestall lipofuscin accumulation can be seen in vivo in that primates subjected to a life-long carotenoid deficiency develop lipofuscin-related damage (drusen) much earlier than primates fed normal diets ([@b61-opth-1-25]).

Among the various components that make up lipofuscin is a retinal-derived compound called A2-PE ([@b46-opth-1-25]). A2-PE is a photosensitizing fluorophore (a molecule that absorbs light energy and releases it as fluorescence at a different wavelength) that creates oxygen free radicals when exposed to blue light. LZ are efficient quenchers of the photochemical oxidation caused by A2-PE---more so than alpha-tocopherol, another biological antioxidant ([@b45-opth-1-25]). Through this mechanism, LZ may help reduce the retina damage caused by lipofuscin in the RPE. As much as half of the lifetime accumulation of lipofuscin in RPE may occur in the first five years of life ([@b89-opth-1-25]; [@b24-opth-1-25]). Increasing MP earlier in life could theoretically slow the accumulation of lipofuscin as well as reduce the free radical oxidants that it produces. Given the low risk and clear potential benefit, it would be prudent to increase lutein consumption earlier in life while further evidence of its benefits emerge.

![Plasma lutein and zeaxanthin concentrations at birth and one month of age for breastfed and formula-fed infants. The bar graphs were derived from the original study data presented in [@b42-opth-1-25].](opth-1-25f1){#f1-opth-1-25}

![The absorbance spectra of macular pigment (MP) measured ex vivo (derived from tabular data in [@b36-opth-1-25]) shown with the blue light hazard function (BHF) (derived from [@b3-opth-1-25]).](opth-1-25f2){#f2-opth-1-25}

![The relation between macular pigment optical density (measured at 460 nm, 1-degree test) and intrinsic noise within the scotopic system (Y = 0.87 + −0.43X). *r* = −0.38; *p* \< 0.01; and n = 39 (mean age = 40; SD = 8 years). Macular pigment was measured at 460 nm using a one-degree test stimulus and a psychophysical technique based on heterochromatic flicker photometry. For details regarding the procedure and apparatus see Wooten et al 1999. Scotopic thresholds were assessed in Maxwellian view using a 1.85-deg, 510-nm circular test stimulus located at 10° eccentricity in the left visual field using a two-alternative forced-choice paradigm (an average of 200 trials per participant was obtained). Individual trials were transformed into binomial data (the inverse of the normal probability integral) and then fit with a weighted linear regression. We then defined "intrinsic noise" as the average deviation from this line (see [@b31-opth-1-25]).](opth-1-25f3){#f3-opth-1-25}

###### 

Published milk lutein concentrations

  **Location**              **Days postpartum**   **Lutein concentration (mcg/L)^a^**                    **Reference**
  ------------------------- --------------------- ------------------------------------------------------ --------------------
  Germany (n = 21)          Day 4 and 19          93 ± 48 (day 4)                                        ([@b72-opth-1-25])
  50 ± 21 (day 19)                                                                                       
  Ireland (n = 13)          1 to 41 days          80 (7--193)[b](#tfn2-opth-1-25){ref-type="table-fn"}   ([@b41-opth-1-25])
  United Kingdom (n = 50)   1--12 months          15 ± 1                                                 ([@b13-opth-1-25])
  Brazil (n = 49)           30 to 120 days        3 ± 1                                                  ([@b58-opth-1-25])
  United States (n = 12)    \< 6 months           11 ± 1                                                 ([@b14-opth-1-25])
  United States (n = 19)    4--32 days            146 ± 99 (day 4)                                       ([@b28-opth-1-25])
  65 ± 36 (day 16)                                                                                       
  58 ± 44 (day 31)                                                                                       
  Australia (n = 53)        1--12 months          15 ± 1                                                 ([@b13-opth-1-25])
  Canada (n = 55)           1--12 months          17 ± 1                                                 ([@b13-opth-1-25])
  Chile (n = 51)            1--12 months          32 ± 3                                                 ([@b13-opth-1-25])
  China (n = 52)            1--12 months          43 ± 5                                                 ([@b13-opth-1-25])
  Japan (n = 51)            1--12 months          44 ± 2                                                 ([@b13-opth-1-25])
  Mexico (n = 50)           1--12 months          25 ± 2                                                 ([@b13-opth-1-25])
  Philippines (n = 60)      1--12 months          20 ± 2                                                 ([@b13-opth-1-25])
  United States (n = 49)    1--12 months          15 ± 1                                                 ([@b13-opth-1-25])

**Notes:** ^a^mean ± SEM unless noted otherwise; converted from published units into μg/L for consistency; shaded rows are European data;

median and range; converted from nmol/g lipid using estimated 34 g lipid/L average from [@b28-opth-1-25].
